Rotavirus vaccination: a concise review T. Vesikari Clinical Microbiology and Infection Volume 18, Pages 57-63 (October 2012) DOI: 10.1111/j.1469-0691.2012.03981.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions
FIG 1 Distribution of severity scores on a 20-point scale of cases of acute rotavirus gastroenteritis in infants followed prospectively for about 1 year after vaccination with three doses of rhesus-human reassortant tetravalent rotavirus vaccine or placebo. A score $GT11 is generally regarded as indicative of severe rotavirus gastroenteritis. The line shows point estimates of vaccine efficacy against rotavirus gastroenteritis from score $GT6 to score $GT15. From ref. [17]. Clinical Microbiology and Infection 2012 18, 57-63DOI: (10.1111/j.1469-0691.2012.03981.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions